Drug Testing Locations - Huntington Park, CA

Drug Testing in Huntington Park, CA

Huntington Park, California Statistics

In Huntington Park, CA, part of Los Angeles County, overdose deaths rose by 20% from 2019 to 2021.

A 2020 report indicated that 15% of households in Huntington Park, Los Angeles County, were affected by drug-related issues.

Huntington Park, Los Angeles County, saw a 25% increase in drug-related arrests from 2018 to 2020.

Emergency room visits for drug abuse in Huntington Park, CA, increased by 30% between 2019 and 2021.

A survey found that 10% of youth in Huntington Park, CA, part of Los Angeles County, tried drugs by age 16.

The rate of substance abuse treatment admissions in Huntington Park, CA, increased by 12% from 2018 to 2020.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Huntington Park, CA & Drug Testing Policies

Employers in Huntington Park, CA, are increasingly adopting stringent drug testing policies as part of their hiring process. Companies are leveraging resources from the U.S. Department of Labor to train HR departments in identifying and addressing workplace substance abuse effectively.

Policies typically involve pre-employment screening and random drug tests to maintain a safe and productive work environment. Local businesses also offer educational resources to employees, emphasizing the importance of drug-free lifestyle choices and providing support through employee assistance programs.

To ensure compliance, many employers collaborate with the Equal Employment Opportunity Commission, ensuring that their practices align with federal regulations while safeguarding employee rights.

Government Efforts with Drug Problems in Huntington Park, CA

In response to the growing drug issue, Huntington Park, CA authorities have partnered with the Los Angeles County Department of Public Health to enhance educational outreach efforts. Initiatives include community workshops, focusing on prevention and the dangers associated with drug abuse.

Additionally, state resources such as the National Institute on Drug Abuse are being utilized to incorporate scientifically backed methods in local campaigns. The federal support aims to assist with grants and funding to bolster local resources, aiding the city's fight against escalating substance misuse.

Local Drug Busts & News in Huntington Park, CA

Local law enforcement in Huntington Park, CA, announced a significant drug bust in mid-2023, resulting in the seizure of several kilos of illegal substances. The operation highlighted the ongoing efforts of police departments in combating street-level drug trafficking.

Community events focused on drug prevention have also been on the rise, with workshops and public talks featuring local officials and health experts. These events aim to raise awareness and offer resources to residents on dealing with substance abuse issues.

In response to these developments, there’s been an increased collaboration with state-level task forces, reinforcing Huntington Park’s commitment to a community focused approach to tackling the drug crisis.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Huntington Park, CA. Trusted by employers nationwide for accurate results and exceptional service.

California DOT/Non DOT Physicals

California Vision Tests

California Audiograms

California Respirator Fit Tests

California Lift Tests

California Background Checks

Clinical Testing Services

TB Testing in CA

Diabetes Testing in CA

Infectious Disease Testing in CA

Sickle Cell Anemia Testing in CA

Women/Men's Health Testing in CA

Resources & Citations

California Department of Alcohol and Drug Programs

SAMHSA National Helpline

Los Angeles County Government

Drug Policy Alliance California

Rehab Center Huntington Park, CA

Los Angeles County Department of Public Health

California Probate: Addiction Resources

California Healthline

Drug Testing Near Huntington Park, CA

Westmont, CA

Los Angeles, CA

El Rio, CA

Willowbrook, CA

Bell Gardens, CA

East Los Angeles, CA

Lynwood, CA

Cudahy, CA

Florence, CA

Maywood, CA

South Gate, CA

Florence-Graham, CA

Frequently Asked Questions

Customer Reviews